Form 8-K - Current report:
SEC Accession No. 0001558370-25-007954
Filing Date
2025-05-16
Accepted
2025-05-16 17:15:24
Documents
14
Period of Report
2025-05-14
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20250514x8k.htm   iXBRL 8-K 40206
2 EX-16.1 cydy-20250514xex16d1.htm EX-16.1 4419
  Complete submission text file 0001558370-25-007954.txt   156324

Data Files

Seq Description Document Type Size
3 EX-101.SCH cydy-20250514.xsd EX-101.SCH 3265
4 EX-101.LAB cydy-20250514_lab.xml EX-101.LAB 14108
5 EX-101.PRE cydy-20250514_pre.xml EX-101.PRE 9207
16 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20250514x8k_htm.xml XML 4303
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 25960588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)